Wedbush Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $63
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
Wedbush analyst Robert Driscoll maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $60 to $63.
Wedbush analyst Robert Driscoll maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $60 to $63.